HKSTP is pleased to invite you joining the announcement event on 31 March 2026 (Tuesday) to hear directly from HKSTP and Charles River Laboratories leadership about how to leverage Hong Kong's first GLP facility - Drug Safety Testing Center (DSC) and its expanded services for your preclinical research and development, plus the simple next steps to engage DSC.
This strategic collaboration (effective 1 April 2026) enhances DSC's capabilities to deliver world-class GLP-compliant testing services while driving higher facility utilisation through Charles River's innovative service models, including the CRADL® platform.
About Charles River Laboratories
Charles River Laboratories is a leading global contract research organization supporting drug discovery and preclinical development for pharmaceutical, biotechnology, and academic clients worldwide. The company operates more than 150 facilities in over 20 countries with a workforce of over 21,000 professionals. Over the past five years, Charles River has worked on more than 80% of drugs approved by the U.S. Food and Drug Administration (FDA), illustrating its central role in advancing new therapies to patients.
You're invited to our announcement event:
Date: 31 March 2026 (Tuesday)
Time: 13:30 - 15:00 (13:15 check-in time)
Venue: Inno2, 2/F, Building 17W, Hong Kong Science Park
Agenda:
13:30 Welcome Address
13:45 Group Photo
13:50 HKSTP DSC X CRL Exclusive Service Introduction
14:20 Drug Development Consulting (on-site service kiosk support to provide service recommandation to meet your project needs)
15:00 Event Ends
Light refreshments will be served during the event.
Please RSVP by 29 March to reserve your place.
Can't make it to this event? No worries! Just fill out this form, and our team will get in touch with you personally.